Biggest News Aggregation in the World
📰 Closure Glaucoma News

Closure Glaucoma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Closure Glaucoma. Real-time updates on events, politics, business and more.

World Glaucoma Day 2024: Expert Debunks Glaucoma Myths And Shares Tips To Manage The Eye Disease

World Glaucoma Day is observed annually on March 12th. This day is dedicated to raising awareness about glaucoma, a group of eye conditions that can lead to optic nerve damage and vision loss. Glaucoma often develops gradually and is characterized by increased pressure in the eyes, which can damage the optic nerve. Read on to know symptoms, myths and misconceptions, and preventive measures. , Health News, Times Now
New Delhi Uma Malliah Image Credits World Glaucoma Day Glaucoma Day Senior Consultant

Glaucoma: Lack Of Timely Treatment Can Lead To Blindness - Check Risks And Symptoms

Glaucoma Awareness Month: Several factors increase the risk of developing glaucoma. Regular eye check-ups, especially for those with risk factors, are paramount, as is awareness because often, it goes undetected in its initial stages. 
Ritika Sachdev National Glaucoma Awareness Month Services Ophthalmologist National Glaucoma Awareness Additional Director Medical Services
Source: india.com

Sun Pharma Announces Drizalma Sprinkle™ (duloxetine delayed-release capsules) is Now Covered by Most Medicare Part D Plans

Share this article Share this article PRINCETON, N.J., March 9, 2021 /PRNewswire/ -- Sun Pharmaceutical Industries, Inc. (Sun Pharma), a wholly owned subsidiary of Mumbai-based Sun Pharmaceutical Industries Limited, today announced that the top 10 Medicare Part D plans, which include 91% of eligible U.S. lives, now cover Drizalma Sprinkle™. Drizalma Sprinkle™ is one of three sprinkle formulation products in Sun Pharmas long-term care (LTC) portfolio, which are prescribed inside and outsid...
United States Sun Pharma Sun Phrama Mark Hagler Sun Pharmaceutical Industries Prnewswire Sun Pharmaceutical Industries Inc

Global Antiglaucoma Drugs Market Report 2020: COVID-19 Impact and Recovery - Forecast to 2023, 2025 & 2030

Share this article Share this article ResearchAndMarkets.coms offering. This report describes and evaluates the global antiglaucoma drugs market. It covers 2015 to 2019, termed the historic period, and 2019 to 2023 termed the forecast period, along with further forecasts for the periods 2023-2025 and 2025-2030. The global antiglaucoma drugs market reached a value of nearly $6,591.8 million in 2019, having increased at a compound annual growth rate (CAGR) of 4.2% since 2015. The market is expec...
United States Asia Pacific Laura Wood Santen Pharmaceutical Co Ltd Custom Research Santen Pharmaceuticals Co Ltd

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science